Jarkowski A 3rd - Search Results

1

Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue".

Jarkowski A 3rd, Norris L, Trinh VA. Jarkowski A 3rd, et al. Ann Pharmacother. 2014 Nov;48(11):1456-68. doi: 10.1177/1060028014544165. Epub 2014 Jul 23. Ann Pharmacother. 2014. PMID: 25056920 Review.

2

Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.

Jarkowski A 3rd, Hare R, Loud P, Skitzki JJ, Kane JM 3rd, May KS, Zeitouni NC, Nestico J, Vona KL, Groman A, Khushalani NI. Jarkowski A 3rd, et al. Am J Clin Oncol. 2016 Dec;39(6):545-548. doi: 10.1097/COC.0000000000000088. Am J Clin Oncol. 2016. PMID: 24879468

3

BRAF and beyond: Tailoring strategies for the individual melanoma patient.

Jarkowski A 3rd, Khushalani NI. Jarkowski A 3rd, et al. J Carcinog. 2014 Feb 7;13:1. doi: 10.4103/1477-3163.126759. eCollection 2014. J Carcinog. 2014. PMID: 24737949 Free PMC article. Review.

4

Immunotherapy in Melanoma: Recent Advances and Promising New Therapies.

Saraceni MM, Khushalani NI, Jarkowski A 3rd. Saraceni MM, et al. Among authors: jarkowski a 3rd. J Pharm Pract. 2015 Apr;28(2):193-203. doi: 10.1177/0897190014527317. Epub 2014 Mar 27. J Pharm Pract. 2015. PMID: 24674910

5

Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings.

Jarkowski A 3rd, Nestico JS, Vona KL, Khushalani NI. Jarkowski A 3rd, et al. J Oncol Pharm Pract. 2014 Feb;20(1):47-50. doi: 10.1177/1078155213476723. Epub 2013 Mar 19. J Oncol Pharm Pract. 2014. PMID: 23512270

6

Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor.

Jarkowski A 3rd, Hare R, Francescutti V, Wilkinson N, Khushalani N. Jarkowski A 3rd, et al. Anticancer Res. 2011 Oct;31(10):3429-32. Anticancer Res. 2011. PMID: 21965757

7

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.

Jarkowski A 3rd, Forrest A, Sweeney RP, Tan W, Segal BH, Almyroudis N, Wang ES, Wetzler M. Jarkowski A 3rd, et al. J Oncol Pharm Pract. 2012 Mar;18(1):91-6. doi: 10.1177/1078155211402107. Epub 2011 Apr 26. J Oncol Pharm Pract. 2012. PMID: 21521799

8

Heart failure caused by molecularly targeted therapies for cancer.

Jarkowski A 3rd, Glode AE, Spangenthal EJ, Wong MK. Jarkowski A 3rd, et al. Pharmacotherapy. 2011 Jan;31(1):62-75. doi: 10.1592/phco.31.1.62. Pharmacotherapy. 2011. PMID: 21182360 Review.

9

Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.

Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd, Forrest A, Bulitta JB, Tsuji BT. Lim LM, et al. Among authors: jarkowski a 3rd. Pharmacotherapy. 2010 Dec;30(12):1279-91. doi: 10.1592/phco.30.12.1279. Pharmacotherapy. 2010. PMID: 21114395 Free PMC article. Review.

10

Treatment of concurrent metastatic renal cell carcinoma and chronic myelogenous leukemia--easier said than done? A case report.

Al-Najjar F, Jarkowski A 3rd. Al-Najjar F, et al. Among authors: jarkowski a 3rd. J Oncol Pharm Pract. 2011 Dec;17(4):436-9. doi: 10.1177/1078155210382060. Epub 2010 Sep 16. J Oncol Pharm Pract. 2011. PMID: 20847086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters